Summary of Classification and Labelling
General Information
EC / List no.
|
Name |
CAS Number
|
|---|---|---|
| 685-286-0 | 7-[2-[4-[4-[(2-Methoxyethoxy)phenyl]-1-piperazinyl]ethyl]- 2-(2-furanyl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5- e]pyrimidin-5-amine | 377727-87-2 |
Notified classification and labelling according to CLP criteria
| Classification | Labelling | Specific Concentration limits, M-Factors | Notes | Classification affected by Impurities / Additives
|
Additional Notified Information
|
Number of Notifiers
|
Joint Entries
|
||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hazard Class and Category Code(s) | Hazard Statement Code(s) | Hazard Statement Code(s) | Supplementary Hazard Statement Code(s) | Pictograms, Signal Word Code(s) | |||||||
| Eye Irrit. 2 | H319 | H319 |
GHS07 GHS08 GHS09 Dgr |
M(Chronic)=1 |
State/Form
|
35 | View details | ||||
| Repr. 2 | H361 (H361fd: Suspect...) | H361 | |||||||||
| STOT RE 1 | H372 (Central nervous...) | H372 | |||||||||
| Aquatic Chronic 1 | H410 | H410 | |||||||||
| Repr. 2 | H361 (May damage the ...) | H361 |
GHS08 Dgr |
State/Form
|
10 | View details | |||||
| STOT RE 1 | H372 (other:Central N...) | H372 (Central Nervous...) | |||||||||
| STOT RE 1 | H372 (Central Nervous...) | H372 (Central Nervous...) | |||||||||
Number of Aggregated Notifications: 2